Unlocking the Future of Medicine: Universal Protein Degradation with 3C Therapeutics.

At 3C Therapeutics, we are pioneering the next generation of targeted therapies. Our innovative TriCore platform directly confronts the limitations of traditional drug discovery, enabling the universal adoption of potent intracellular protein degraders with unprecedented precision. We design our degraders to eliminate disease-causing proteins by harnessing the cell's internal proteasome, redefining therapeutic possibilities.

Overcoming the inherent limitations of traditional targeted protein degradation, 3C Therapeutics introduces a proprietary platform for universal adoption of potent intracellular protein degraders and antibody delivery.